Nancy Lane
Institution Name:
University of California, Davis
Total Awards:
2
Award Value:
$18,339,106
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Disease Team Therapy Planning I | University of California, Davis | Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis | $107,750 |
| Disease Team Therapy Development - Research | University of California, Davis | Treatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells | $18,231,356 |
Total: $18,339,106.00 |
Publications
- Bone 2014 Targeted delivery of mesenchymal stem cells to the bone. (PubMed: 25173607)
- Stem Cells 2016 Improved Mobilization of Exogenous Mesenchymal Stem Cells to Bone for Fracture Healing and Sex Difference. (PubMed: 27334693)
- Calcif Tissue Int 2017 A Novel Hybrid Compound LLP2A-Ale Both Prevented and Rescued the Osteoporotic Phenotype in a Mouse Model of Glucocorticoid-Induced Osteoporosis. (PubMed: 27679514)
- Bone Rep 2018 Prevalence of glucocorticoid induced osteonecrosis in the mouse is not affected by treatments that maintain bone vascularity. (PubMed: 30510976)
- BMC Pharmacol Toxicol 2020 A new anabolic compound, LLP2A-Ale, reserves periodontal bone loss in mice through augmentation of bone formation. (PubMed: 33187558)